Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals Limited receives USFDA Final Approval for Sacubitril and Valsartan Tablets.